DIADEMA PARTNERS LP

Position in RVMD — Revolution Medicines, Inc.

CIK 2026172 MORRISTOWN, NJ

Back to RVMD Full portfolio

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,864,802

+$4,916,159 QoQ

Shares Held

80,872

+118.5% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

3.51%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$12,204,875

PutShares

125,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. RVMD ranks #7 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	525,181	$17,089,389
2	COGT	Cogent Biosciences, Inc.	322,764	$12,423,186
3	JAZZ	Jazz Pharmaceuticals plc	54,755	$10,351,432
4	TERN	Terns Pharmaceuticals, Inc.	181,752	$9,581,965
5	ABVX	Abivax S.A.	75,944	$8,456,364
6	BMRN	Biomarin Pharmaceutical Inc	148,229	$8,373,456
7	RVMD	Revolution Medicines, Inc. This page	80,872	$7,864,802
8	KOD	Kodiak Sciences Inc.	192,962	$7,355,711

All Filings in RVMD

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,864,802	80,872	-35.6%	Shares	Sole	2026-05-15
2026-03-31	$12,204,875	125,500	+239.0%	Put	Sole	2026-05-15
2025-12-31	$2,948,643	37,020	-37.3%	Shares	Sole	2026-02-17
2025-09-30	$2,758,989	59,079	-25.3%	Shares	Sole	2025-11-14
2025-06-30	$2,909,316	79,079	-60.5%	Shares	Sole	2025-08-14
2025-06-30	$7,358,000	200,000	—	Call	Sole	2025-08-14
No filing history on record for this holder in this stock.